Investigating the role of cytotoxins in Chlamydia infections
Official title: Role of putative cytotoxins in Chlamydia infection
Funded at University of Kentucky · NIH-10984199 · Data updated 2026-11-12
This study is looking at how certain proteins in Chlamydia might affect infections, using mice to learn more about the differences between Chlamydia types and how these proteins interact with infected cells, which could help us find better ways to treat Chlamydia infections.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project start | August 21, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $215,453 |
| NIH project number | 1R21AI178108-01A1 |
| Project ID | NIH-10984199 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have been diagnosed with Chlamydia infections or are at risk of such infections.
✕Less likely to help
Patients who do not have Chlamydia infections or are not at risk for these infections may not benefit from this research.
What this research studies
This research focuses on understanding how certain proteins, known as putative cytotoxins, affect Chlamydia infections, particularly in the context of different Chlamydia species. By using a murine model, the study aims to explore the genetic differences that influence infection biology and the mechanisms by which these cytotoxins may impact infected cells. The researchers have developed methods to delete specific toxin genes in Chlamydia muridarum, allowing for a more detailed analysis of their role in infection. This approach could lead to new insights into how Chlamydia causes disease and how to potentially combat it.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for Chlamydia infections.
How similar studies have gone: While the specific approach of investigating putative cytotoxins in Chlamydia is novel, similar research has shown promise in understanding other infectious diseases.
Where this research is happening
-
University of Kentucky
Lexington, United States Active
Researchers
- Principal investigator: Fields, Kenneth a — University of Kentucky
- Study coordinator: Fields, Kenneth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.